The excitement surrounding integrins has been growing over the past few years, culminating in recent clinical success, innovative biology and medicinal chemistry advancements blazing the way to tackle previously undruggable disease modalities through novel integrin targets

The Integrin-Targeted Drug Discovery Summit is not just the first, but the only industry-driven event sharing pioneering advances, expert insights and exclusive updates on the field of integrin drug discovery and development – from solid tumors to autoimmune diseases, from ophthalmology to fibrosis, revealing the therapeutic windows of integrins!

With the vast potential of integrins as targets, this inaugural 3-day summit will unite industry trailblazers including Pliant Therapeutics, Morphic Therapeutics and 7 Hills Pharma with academic leaders, such as pioneer Dean Sheppard, to delve into the biology and chemistry of different integrins classes, MoA and explore the best approach to regulate integrins, driving translational and clinical success.

Join a global community of 80+ experts on August 17-19 to tackle issues of safety, selectivity and specificity in drug development, further your understanding of the structure and function of integrins to inform your R&D decisions and leverage the lessons learned over the past 20 years to enhance your bed to bedside progression.

Find out more >> https://ter.li/g4kols